関節痛注射市場 - 2031年の成長予測、統計および事実

  • Report Code : TIPRE00003536
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 162
Buy Now

[調査レポート]関節痛注射市場は、2020年の36億6,745万米ドルから2028年までに69億9,688万米ドルに達すると予想されています。 2021 年から 2028 年にかけて 8.5% の CAGR で成長すると推定されています。



関節痛注射は、激しい痛みをより早く軽減し、関節の炎症を軽減します。市場で入手可能ないくつかの種類の注射には、コルチコステロイド注射、ヒアルロン酸 (HA) 注射、多血小板血漿 (PRP) 注射、胎盤組織基質 (PTM) 注射などがあります。関節痛注射市場の成長は、筋骨格系疾患の罹患率の高さやスポーツ傷害の増加などの要因に起因すると考えられます。ただし、関節修復療法の高コストが市場の成長を妨げています



関節痛注射市場の有利な地域



市場洞察



筋骨格系疾患の高い有病率

筋骨格系疾患は、首、肩、手首、背中、腰、脚、膝、足の筋肉、骨、関節に影響を及ぼす病状です。これらの疾患には、腱炎、手根管症候群、変形性関節症、関節リウマチ(RA)、線維筋痛症、骨折などが含まれます。 2018年に更新された世界保健機関(WHO)のファクトシートによると、筋骨格疾患は世界中で障害の2番目に大きな原因となっています。同報告書によると、筋骨格系疾患の有病率とその影響は、世界中で高齢化人口の増加と非感染性疾患(NCD)の危険因子の有病率の増加に伴い増加すると予想されています。 2016 年の米国整形外科医学会の年次総会データによると、米国では成人の約 2 人に 1 人が筋骨格系疾患に苦しんでいます。さらに、疾病管理予防センター (CDC) によると、関節炎は激しい痛みを引き起こし、米国では毎年数百万人が苦しんでいます。関節炎患者の約 4 人に 1 人、つまり合計約 5,400 万人の患者のうち約 1,500 万人が、重度の関節炎関連の関節痛を経験しています。



さらに、変形性関節症 (OA) は、世界で最も一般的な関節疾患の 1 つです。米国、骨間の関節軟骨の破壊によって引き起こされます。これは、変形性関節疾患または「磨耗」としても知られています。関節炎。アメリカ疾病予防管理センター (CDC) によると、米国では 3,250 万人以上の成人が変形性関節症に苦しんでいます。同様に、国民保健サービス (NHS) によると、英国では 1,000 万人以上が関節炎または関節に影響を与える同様の症状を患っています。 Bupa Health Insurance によると、変形性関節症は英国で蔓延している関節炎の最も一般的な形態であり、国内の 45 歳以上の人の約 3 分の 1、つまり約 875 万人が罹患しています。したがって、さまざまな国での筋骨格系疾患の有病率の高さにより、筋骨格系疾患に対して実施される治療法の数が増加しており、それによって関節痛注射市場の成長が促進されています。



薬物ベースの洞察



< p>関節痛注射市場は、薬剤ごとにヒアルロン酸、コルチコステロイドなどに分類されます。コルチコステロイドセグメントは、2020年に市場で最大のシェアを保持しており、予測期間中に最高のCAGRを記録するとさらに予想されています。



関節痛注射市場、薬剤別 - 2020年および2028年



関節タイプに基づく洞察



関節タイプに基づいて、関節痛注射市場は膝、足と足首、肩と肘、腰、その他の用途に分類されます。膝セグメントは2020年に最大の市場シェアを保持しており、予測期間中に市場で最高のCAGRを記録すると予想されています。



流通チャネルベースの洞察



流通チャネルに基づいて、関節痛注射市場は小売薬局、病院薬局などに分割されます。創傷治療セグメントは 2020 年に最大の市場シェアを保持し、骨移植片セグメントは予測期間中に市場で最高の CAGR を記録すると推定されています。



戦略的洞察



製品の発売承認は、世界的な拠点と製品ポートフォリオを拡大するために企業が一般的に採用する戦略です。さらに、関節痛注射市場のプレーヤーは、顧客を拡大するためのコラボレーション戦略に焦点を当てており、これにより、世界的にブランド名を維持することが可能になります。



関節痛注射市場 – 薬剤別





  • ヒアルロン酸

  • コルチコステロイド

  • その他


関節痛注射市場 - 関節タイプ別






  • 足と足首

  • 肩と肘

  • 股関節

  • その他


関節痛注射市場 - 流通チャネル別





  • 小売薬局

  • 病院薬局

  • その他


共同鎮痛剤市場 - 地理別





  • 北米

    • 米国

    • カナダ

    • メキシコ


    < /li>
  • ヨーロッパ

    • フランス

    • ドイツ

    • イタリア

    • イギリス

    • スペイン

    • その他のヨーロッパ



  • アジア太平洋 (APAC)

    • 中国

    • インド

    • 韓国

    • 日本

    • オーストラリア

    • その他のアジア太平洋地域



  • 中東およびアフリカ (MEA)< ul>
  • 南アフリカ

  • サウジアラビア

  • アラブ首長国連邦

  • 中東およびアフリカのその他の地域



< li>中南米 (SCAM)

  • ブラジル

  • アルゼンチン

  • 南中米のその他の地域



< /ul>

会社概要





  • 中外製薬株式会社

  • Bioventus Inc.

  • Fidia Pharma USA Inc.

  • >
  • Flexion Therapeutics, Inc.

  • 生化学工業株式会社

  • Ferring BV

  • サノフィ

  • Anika Therapeutics, Inc.

  • >
  • テバ ファーマシューティカル

  • OrthogenRx, Inc.


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are joint pain injections?

Joint pain injections are medicinal fluids inserted in the patient’s body to get faster relief from severe pain. The joint pain injections are used to reduce inflammation in the joints. There are several types of injections available in the market which are corticosteroids injections, hyaluronic acid (HA) injections, platelet-rich plasma (PRP) injections and placental tissue matrix (PTM) injections.

What are the driving factors for the joint pain injection market across the globe?

The global joint pain injection market growth is mainly attributed to factors such the high prevalence of musculoskeletal disorders and increasing number of sports injuries. However, the high costs of joint repair therapies hinder the market growth.

Who are the major players in the joint pain injection market?

The joint pain injection market majorly consists of the players such as Chugai Pharmaceutical Co., Ltd., Teva Pharmaceuticals, Bioventus Inc., Fidia Pharma USA Inc., Flexion Therapeutics, Inc., SEIKAGAKU CORPORATION, Ferring B.V., Sanofi, Anika Therapeutics, Inc., and OrthogenRx among others.

The List of Companies - Joint Pain Injection Market

  1. Chugai Pharmaceutical Co., Ltd.              
  2. Bioventus Inc.                
  3. Fidia Pharma USA Inc.                
  4. Flexion Therapeutics, Inc.          
  5. SEIKAGAKU CORPORATION       
  6. Ferring B.V.     
  7. Sanofi              
  8. Anika Therapeutics, Inc.             
  9. Teva Pharmaceutical                  
  10. OrthogenRx, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports